Thursday, 18 April 2024

[the_ad_group id="2845"]


Flora Growth Corp. Announces Launch of Proposed Underwritten Public Offering of Common Shares By

Evergy PT Lowered to $68 at Credit Suisse

[the_ad id="21475"]


Fort Lauderdale, Florida–(Newsfile Corp. – April 3, 2024) – Flora Growth Corp. (NASDAQ: FLGC) (the “Company”), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, today announced that it has commenced a public offering to offer and sell Common Shares. The Company intends to use the net proceeds from this offering for general corporate and working capital needs.

In addition, the Company expects to grant Aegis Capital Corp. a 45-day option to purchase additional Common Shares of up to 15% of the number of Common Shares sold in the Offering solely to cover over-allotments, if any.

The Company’s Common Shares is trading on the Nasdaq Capital Market under the symbol “FLGC”. The final terms of the offering will depend on market and other conditions at the time of pricing, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Aegis Capital Corp. is acting as the sole book-running manager for the offering. Dorsey & Whitney LLP is acting as counsel to the Company. Kaufman & Canoles, P.C. is acting as counsel to Aegis Capital Corp.

The offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-274204) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on September 6, 2023. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at, or by telephone at +1 (212) 813-1010.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Flora Growth Corp.

Flora Growth Corp. is a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28…

Click Here to Read the Full Original Article at All News…


[the_ad id="21476"]